Suchergebnis | Hamburg Open Science

Facetten

48 Einträge gefunden

Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study
2021 - Forschungsinformationssystem des UKE - frei zugänglich
Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study
2017 - Forschungsinformationssystem des UKE - frei zugänglich
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
2013 - Forschungsinformationssystem des UKE
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
2012 - Forschungsinformationssystem des UKE
Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the framingham offspring cohort
2011 - Forschungsinformationssystem der UHH - frei zugänglich
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
2011 - Forschungsinformationssystem des UKE
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
2011 - Forschungsinformationssystem der UHH
Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.
2011 - Forschungsinformationssystem des UKE
Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma.
2011 - Forschungsinformationssystem des UKE
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
2011 - Forschungsinformationssystem des UKE
Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
2010 - Forschungsinformationssystem des UKE
The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.
2010 - Forschungsinformationssystem des UKE
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
2010 - Forschungsinformationssystem des UKE
Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.
2009 - Forschungsinformationssystem des UKE
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
2009 - Forschungsinformationssystem des UKE
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.
2009 - Forschungsinformationssystem des UKE
Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.
2009 - Forschungsinformationssystem des UKE
L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
2009 - Forschungsinformationssystem des UKE
Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.
2009 - Forschungsinformationssystem des UKE
Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.
2009 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study

Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study

Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.

Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.

Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the framingham offspring cohort

Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.

Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort

Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.

Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma.

Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.

Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.

Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.

Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.

Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.